Ovariectomy and 17beta-estradiol Replacement Do Not Alter Beta-amyloid Levels in Sheep Brain

Overview

Journal Endocrinology

Publisher Oxford University Press

Specialty Endocrinology

Date 2009 Mar 14

PMID 19282379

Citations 4

Authors

A M Barron

M Cake

G Verdile

R N Martins

Affiliations

Soon will be listed here.

Abstract

The benefits of estrogen replacement as a preventative treatment for Alzheimer's disease (AD) are subject to debate. Because the effects of estrogen depletion and replacement on accumulation of the neurotoxic beta-amyloid (A beta) peptide in transgenic animal models of AD have been variable, we examined A beta levels and oxidative stress in a nontransgenic animal model. Sheep have traditionally been used as a model for human reproduction; however because they share 100% sequence homology with the human form of A beta, they may also have potential as a nontransgenic model for A beta biology. The effect of ovariectomy and estrogen replacement administered for 6 months via slow-release implant was examined in the brain of 4.5-yr-old sheep. A beta levels were measured by ELISA, and protein levels of the amyloid precursor protein (APP), APP C-terminal fragments (C100), and presenilin-1 were examined semiquantitatively by Western blot as markers of APP processing. Markers of oxidative stress were examined semiquantitatively by Western blot [4-hydroxy-2(E)-nonenal] and oxyblot (protein carbonyls). We found no effects of estrogen depletion and supplementation in terms of AD-related biochemical markers, including A beta levels, APP processing, and oxidative stress levels. Evidence of a trend toward increased P450 side-chain cleavage enzyme levels in the hippocampus of ovariectomized and estrogen supplemented sheep suggests that neurosteroidogenesis may compensate for gonadal estrogen depletion; however, these findings cannot explain the lack of effect of estrogen supplementation on APP processing. It is possible that supraphysiological doses of estrogen are necessary to yield antiamyloidogenic and antioxidative benefits in ovariectomized sheep.

Citing Articles

First delivery and ovariectomy affect biomechanical and structural properties of the vagina in the ovine model.

Urbankova I, Callewaert G, Blacher S, Deprest D, Hympanova L, Feola A Int Urogynecol J. 2018; 30(3):455-464.

PMID: 29313089 DOI: 10.1007/s00192-017-3535-9.

Sex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for Tregs, estrogen, and IL-6.

Cho J, Kim L, Li Z, Rose N, Vladut Talor M, Njoku D PLoS One. 2013; 8(4):e61186.

PMID: 23577207 PMC: 3618451. DOI: 10.1371/journal.pone.0061186.

Sex hormones, aging, and Alzheimer's disease.

Barron A, Pike C Front Biosci (Elite Ed). 2011; 4(3):976-97.

PMID: 22201929 PMC: 3511049. DOI: 10.2741/E434.

Gonadal hormones and cognitive aging: a midlife perspective.

Henderson V Womens Health (Lond). 2010; 7(1):81-93.

PMID: 21175393 PMC: 3675221. DOI: 10.2217/whe.10.87.

References

Muller M, Schupf N, Manly J, Mayeux R, Luchsinger J . Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol Aging. 2008; 31(10):1758-65. PMC: 2891653. DOI: 10.1016/j.neurobiolaging.2008.10.001. View

Braak H, Braak E, Strothjohann M . Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett. 1994; 171(1-2):1-4. DOI: 10.1016/0304-3940(94)90589-4. View

Petanceska S, Nagy V, Frail D, Gandy S . Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp Gerontol. 2000; 35(9-10):1317-25. DOI: 10.1016/s0531-5565(00)00157-1. View

Levin-Allerhand J, Smith J . Ovariectomy of young mutant amyloid precursor protein transgenic mice leads to increased mortality. J Mol Neurosci. 2002; 19(1-2):163-6. DOI: 10.1007/s12031-002-0027-1. View

Shumaker S, Legault C, Rapp S, Thal L, Wallace R, Ockene J . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289(20):2651-62. DOI: 10.1001/jama.289.20.2651. View

Verdile G, Fuller S, Atwood C, Laws S, Gandy S, Martins R . The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?. Pharmacol Res. 2004; 50(4):397-409. DOI: 10.1016/j.phrs.2003.12.028. View

Espeland M, Rapp S, Shumaker S, Brunner R, Manson J, Sherwin B . Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004; 291(24):2959-68. DOI: 10.1001/jama.291.24.2959. View

Mellon S, Griffin L, Compagnone N . Biosynthesis and action of neurosteroids. Brain Res Brain Res Rev. 2001; 37(1-3):3-12. DOI: 10.1016/s0165-0173(01)00109-6. View

Bowen R, Verdile G, Liu T, Parlow A, Perry G, Smith M . Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004; 279(19):20539-45. DOI: 10.1074/jbc.M311993200. View

10.

Zandi P, Carlson M, Plassman B, Welsh-Bohmer K, Mayer L, Steffens D . Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002; 288(17):2123-9. DOI: 10.1001/jama.288.17.2123. View

11.

Roby K, Larsen D, Deb S, Soares M . Generation and characterization of antipeptide antibodies to rat cytochrome P-450 side-chain cleavage enzyme. Mol Cell Endocrinol. 1991; 79(1-3):13-20. DOI: 10.1016/0303-7207(91)90090-f. View

12.

Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View

13.

Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F . Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology. 1998; 50(4):996-1002. DOI: 10.1212/wnl.50.4.996. View

14.

Lehman M, Goodman R, Karsch F, Jackson G, Berriman S, Jansen H . The GnRH system of seasonal breeders: anatomy and plasticity. Brain Res Bull. 1997; 44(4):445-57. DOI: 10.1016/s0361-9230(97)00225-6. View

15.

Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu E . Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A. 1981; 78(8):4704-7. PMC: 320231. DOI: 10.1073/pnas.78.8.4704. View

16.

Zheng H, Xu H, Uljon S, Gross R, Hardy K, Gaynor J . Modulation of A(beta) peptides by estrogen in mouse models. J Neurochem. 2002; 80(1):191-6. DOI: 10.1046/j.0022-3042.2001.00690.x. View

17.

Green P, Bales K, Paul S, Bu G . Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. Endocrinology. 2005; 146(6):2774-81. DOI: 10.1210/en.2004-1433. View

18.

Tang M, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B . Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996; 348(9025):429-32. DOI: 10.1016/S0140-6736(96)03356-9. View

19.

Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A . A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997; 48(6):1517-21. DOI: 10.1212/wnl.48.6.1517. View

20.

Nelson P, Saper C . Injections of okadaic acid, but not beta-amyloid peptide, induce Alz-50 immunoreactive dystrophic neurites in the cerebral cortex of sheep. Neurosci Lett. 1996; 208(2):77-80. DOI: 10.1016/0304-3940(96)12563-5. View